stocksALPA
ALPA

Alpa Laboratories Ltd.

62.02-0.7 (-1.16%)
24 Aug, 9:59 AM

Annual Reports and Financial Documents

Alpa Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2013201420152016201720182019202020212022202320242025
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Alpa Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General11 Aug 2026
    CLARIFICATION ON BOARD MEETING
    CLARIFICATION ON BOARD MEETING DATE WITH RESPECT TO THE EARLIER SUBMISSION
  2. Board Meeting4 Aug 2026
    Board Meeting Intimation for Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30Th June, 2026
    Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Standalone and Consolidated ....
  3. General29 Jul 2026
    Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For Materiality Of Information
    Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  4. Cessation22 Jul 2026
    Announcement under Regulation 30 (LODR)-Cessation
    Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 , we hereby inform you that Ms. Jyoti Jain has ceased to be an ....
  5. Resignation of Company Secretary / Compliance Officer8 Jul 2026
    Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
    Ms.Yashoda Patidar has resigned from the post of Company Secretary & Complaince Officer w.e.f. 26th July 2026.
  6. Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    We wish to inform that in pursuant of Securities and Exchange Board of India (Prohibition of Insider Trading)(Amendment) Regulation 2018,and Company''s Code of Conduct for Regulating, Monitoring ....
  7. Board Meeting12 May 2026
    Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Standalone & Consolidated ....
  8. Appointment of Company Secretary / Compliance Officer11 Apr 2026
    Appointment of Company Secretary and Compliance Officer
    Appointment of Ms.Yashoda Patidar as the Company Secretary and Complaince Officer of the company w.e.f. April 11,2026.
  9. General9 Apr 2026
    Clarification
    Clarification on the Price Sensitive Information via email dt8th April,2026
  10. Closure of Trading Window20 Mar 2026
    Closure of Trading Window
    The trading Window of the company shall remain closed w.e.f, 01st April 2026 till 48 hours after the declaration of the Financial results by the company for the fourth quarter and financial ....
  11. General9 Mar 2026
    Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinit Shah
  12. Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 20119 Mar 2026
    Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinit Shah
  13. Resignation of Company Secretary / Compliance Officer25 Feb 2026
    Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
    Ms Srashti Chopra has resigned from the post of Company Secreatary and Compliance Officer wef 25th March 2026.
  14. Outcome of Board Meeting11 Feb 2026
    Board Meeting Outcome for Financial Results
    Alpa Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
  15. Board Meeting29 Jan 2026
    Board Meeting Intimation for Consider And Approve The Financial Results For The Period Ended December 31, 2025
    Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the Unaudited Financial results ....
  16. Closure of Trading Window25 Dec 2025
    Closure of Trading Window
    Alpa Laboratories has informed the exchange regarding the closure of trading window pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015
  17. Board Meeting4 Nov 2025
    Board Meeting Intimation for Board Meeting Intimation
    Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve ALPA LABORATORIES LIMITED ....
  18. AGM1 Oct 2025
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    ,Alpa Laboratories Limited has submitted the exchange a copy of Scrutinizer''s Report of AGM held on September 29, 2025.
  19. AGM29 Sept 2025
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Alpa Laboratories has informed the exchange regarding outcome of Annual General Meeting held on September 29, 2025.
  20. Closure of Trading Window27 Sept 2025
    Closure of Trading Window
    Alpa Laboratories has informed the exchange regarding the Closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015

Frequently Asked Questions

Where can I download the annual report of Alpa Laboratories Ltd.?
Annual reports of Alpa Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Alpa Laboratories Ltd.?
Quarterly earnings results and presentations of Alpa Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Alpa Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Alpa Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Alpa Laboratories Ltd.?
Investor presentations and annual day presentations of Alpa Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Alpa Laboratories Ltd.?
Corporate announcements and regulatory filings of Alpa Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Alpa Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Alpa Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Alpa Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Alpa Laboratories Ltd. is INE385I01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Alpa Laboratories Ltd. listed?
Alpa Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is ALPA and the BSE code is -.
Where can I find the shareholding pattern of Alpa Laboratories Ltd.?
The quarterly shareholding pattern of Alpa Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Alpa Laboratories Ltd. on Sharpely?
Share price data for Alpa Laboratories Ltd. is updated as of 24 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.